Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Dauby, Nicolas" or (type any "bookEditor journalEditor issueEditor" and editor="Dauby, Ni...

Add to list
- Journal Article
- A1
- open access
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma

Timothy Devos, Quentin Van Thillo, Veerle Compernolle (UGent) , Tomé Najdovski, Marta Romano, Nicolas Dauby, Laurent Jadot, Mathias Leys, Evelyne Maillart, Sarah Loof, et al.

(2022) EUROPEAN RESPIRATORY JOURNAL. 59.
Add to list
- Journal Article
- open access
Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'"

Nicolas Dauby, Joris Hautekiet, Lucy Catteau, Marion Montourcy, Dominique Van Beckhoven, Emmanuel Bottieau and Els Goetghebeur (UGent)

(2021) INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 57(4).
Add to list
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

Jozefien Declercq (UGent) , Karel Van Damme (UGent) , Elisabeth De Leeuw (UGent) , Bastiaan Maes (UGent) , Cedric Bosteels (UGent) , Simon Tavernier, Stefanie De Buyser (UGent) , Roos Colman (UGent) , Maya Hites, Gil Verschelden, et al.

(2021) LANCET RESPIRATORY MEDICINE. 9(12). p.1427-1438
Add to list
- Journal Article
- A1
- open access
The human fetal thymus generates invariant effector γδ T cells

Paola Tieppo, Maria Papadopoulou, Deborah Gatti, Naomi McGovern, Jerry K. Y. Chan, Francoise Gosselin, Glenn Goetgeluk (UGent) , Karin Weening (UGent) , Ling Ma, Nicolas Dauby, et al.

(2020) JOURNAL OF EXPERIMENTAL MEDICINE. 217(3).
Add to list
- Journal Article
- A1
- open access
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Timothy Devos, Tatjana Geukens, Alexander Schauwvlieghe (UGent) , Kevin K. Arien, Cyril Barbezange, Myriam Cleeren, Veerle Compernolle, Nicolas Dauby, Daniel Desmecht, David Grimaldi, et al.

(2020) TRIALS. 21(1).
Add to list
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19 : a nationwide observational study of 8075 participants

Lucy Catteau, Nicolas Dauby, Marion Montourcy, Emmanuel Bottieau, Joris Hautekiet (UGent) , Els Goetghebeur (UGent) , Sabrina van Ierssel, Els Duysburgh, Herman Van Oyen (UGent) , Chloé Wyndham-Thomas, et al.

(2020) INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 56(4).
Add to list
- Conference Paper
- C3
Clinical work in language-discordant Emergency Department consultations

Antoon Cox, Dominique Cerf, Nicolas Dauby, Philippe Humblé, Shuanyu Lee, Katrijn Maryns (UGent) and Pierre Mols

(2018) CRITICAL CARE. 22(suppl. 1). p.183-184

Academic Bibliography

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma

Reply to "The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of 'goals of care'"

Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial

The human fetal thymus generates invariant effector γδ T cells

A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19 : a nationwide observational study of 8075 participants

Clinical work in language-discordant Emergency Department consultations

Contents

Support

Contact